CAIRO3_2D: CAIRO3, figure 2D

CAIRO3_2DR Documentation

CAIRO3, figure 2D

Description

Kaplan-Meier digitized data from CAIRO3, figure 2D (PMID 25862517). A reported sample size of 558 for a primary endpoint of PFS2 in colorectal cancer.

Usage

CAIRO3_2D

Format

A data frame of 557 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (maintenance, observation)

Source

Simkens LHJ, van Tinteren H, May A, et al. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group. Lancet 2015; 385: 1843–52.

Examples

summary(CAIRO3_2D)

kmplot(CAIRO3_2D)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.